Centers | ||
Edinburgh Drug Discovery | FDA Oncology Center of Excellence Project Catalyst | Chemical Genomics Facility at Purdue Institute for Drug Discovery |
Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of... |
Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation |
The Chemical Genomics Facility is a core facility at Purdue Institute for Drug Discovery that provides expertise and resources needed in the early stage of drug discovery. The services include small molecule libraries, access to automated equipment... Read more |
Partnerships |
Events |
Jobs |
Johns Hopkins BSi Licenses GCPII Assets from EisaiJohns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted... View all Takeda Partners with Florida Hospital & Sanford-Burnham in Obesity AreaTakeda Pharmaceuticals has entered into a collaboration with Florida Hospital and Sanford-Burnham Medical Institute to discover and develop new therapeutic approaches to treat obesity. The two collaboration agreement will involve Takeda providing... View all Elan and University of Cambridge Establish New Innovation CenterUniversity of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in developing innovative therapies to treat Alzheimer's... View all |
No EVENTS for listing |
No Job Posts |


